Crigler-Najjar Syndrome

Not yet reviewed

This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.

Disease overview

Complete (Type I) or partial (Type II) deficiency in UGT1A1 leading to build up of unconjugated bilirubin.

Common symptoms

Type I: Persistent neonatal jaundicerisk of kernicterus (bilirubin encephalopathy) within first monthcausing lethargyhypotonia with episodes of spasticityconvulsionsand risk of lasting brain damage. Type II: milderjaundice during concurrent illnessesand rarely kernicterus.

When to suspect

  • Recommendation 1

    Clinically

  • Recommendation 2

    neonatal jaundice with high unconjugated bilirubin levels without hemolysis. Confirm via genetic testing for mutations in the UGT1A1 gene.

How to test

  • Recommendation 1

    Clinically

  • Recommendation 2

    neonatal jaundice with high unconjugated bilirubin levels without hemolysis. Confirm via genetic testing for mutations in the UGT1A1 gene.

ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.

Treatment

  • Recommendation 1

    Phototherapy, plasmapheresis. Type II may show improved UGT1A1 activity with phenobarbital. Liver transplant is a definitive treatment and is often necessary if a patient stops responding to phototherapy (common as skin thickens with age)

  • Recommendation 2

    some believe transplant should be performed preventatively at an earlier age. Isolated hepatocyte transplant may be a "bridge" while waiting for whole-organ treatment.

Primary care

  • Recommendation 1

    Phototherapy must be provided indefinitely unless liver transplant provided

  • Recommendation 2

    compliance with aggressive phototherapy can be difficult. Patients at increased risk for gallstones, liver fibrosis. Kernicterus is life-threatening, requires immediate phototherapy and transfer to ICU. Thresholds for bilirubin levels by gestational age here. Monitor total and direct serum bilirubin at least every 2 hours

  • Recommendation 3

    monitor for anemia. Obtain blood type as exchange transfusion may be necessary to restore normal bilirubin levels. Additional considerations here. There is ongoing uncertainty about when to offer liver transplant

  • Recommendation 4

    discuss patient preferences early [more]. Patients and families may get support from the American Liver Foundation or Parents of Infants and Children with Kernicterus

Further support

  • Recommendation 1

    Pediatric hepatology, gastroenterology, and genetic counseling is recommended. There are no centers dedicated to treating Crigler-Najjar Syndrome. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.

Clinical trials

Clinical Trials

Sources

No data available

Interested in learning more about Crigler-Najjar Syndrome?

Follow to receive regular updates to the latest research development on this disease via email newsletter.